8-K: Zivo Bioscience Shareholders Elect Director, Ratify Auditor, and Approve Executive Compensation at Annual Meeting

Zivo Bioscience held its annual shareholder meeting on June 11, 2024, where shareholders elected a director, ratified the appointment of an auditor, and approved executive compensation.

Summary

• Zivo Bioscience held its annual shareholder meeting on June 11, 2024.
• Shareholders elected Nola E. Masterson as a Class II director to serve a three-year term until the 2027 annual meeting.
• The appointment of BDO USA, LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
• Shareholders also approved, on an advisory basis, the compensation of the company's named executive officers.
• A total of 1,862,320 shares were represented at the meeting, either in person or by proxy, which is approximately 66.4% of the outstanding shares as of the record date.
• All three proposals were approved by the stockholders.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures and shareholder approvals, indicating a stable and routine business operation. There are no indications of significant positive or negative events.

Positives

• All proposals presented to shareholders were approved, indicating strong shareholder support.
• The election of a Class II director ensures continuity and governance for the company.
• Ratification of the auditor provides assurance of financial oversight.
• Approval of executive compensation suggests shareholder alignment with management's pay structure.

Industry Context

This announcement is a routine corporate governance update following the company's annual shareholder meeting, which is a standard practice for publicly traded companies.

Comparison to Industry Standards

• The shareholder meeting and voting procedures are consistent with standard practices for publicly traded companies in the United States.
• The level of shareholder participation, with 66.4% of shares represented, is within the typical range for annual meetings.
• The election of directors, ratification of auditors, and advisory vote on executive compensation are common agenda items for such meetings.

Management Changes

Stakeholder Impact

• Shareholders have exercised their voting rights and approved the proposals.
• The company has fulfilled its corporate governance obligations.
• The appointment of an auditor ensures financial transparency for stakeholders.

Key Dates

Keywords

Annual Meeting, Shareholders, Director Election, Auditor Ratification, Executive Compensation, Corporate Governance, Voting Results